Senores Pharmaceuticals Limited raises Rs 261 crores from Anchor Investors
Mumbai: Senores Pharmaceuticals Limited has garnered Rs. 260.62 crores from anchor investors ahead of its initial public offering that opens for public subscription on Friday, December 20, 2024. The company informed the bourses that it allocated 66,65,725 equity shares at Rs. 391 per share on Thursday, December 19, 2024, to anchor investors.
Foreign and Domestic Institutions who participated in the anchor included ICICI Prudential Mutual Fund, Aditya Birla Sun Life Insurance, Mahindra ManuLife Large & Mid Cap Fund, Bank of India Multicap Fund, Bank of India Mid & Small Cap Equity & Debt Fund, Ikigai Emerging Equity Fund, SBI General Insurance Company, Troo Capital Fund, Meru Investment Fund PCC- Cell I, Edelweiss Life Insurance Company, Astorne Capital VCC – Arven, Beacon Stone Capital VCC – Beacon Stone I, Goldman Sachs Investment (Mauritius), Ashika Global Securities, Integrated Core Strategies Asia Pte. Ltd., Societe Generale – ODI, Unity Small Finance Bank, Fortune Hands Growth Fund, and Gagandeep Credit Capital Pvt. Ltd.
Out of the total allocation of 66,65,725 equity shares to the anchor investors, 22,99,380 equity shares were allocated to 3 domestic mutual funds through a total of 4 schemes, i.e. 34.50% of the Total Anchor Book Size.
Equirus Capital Private Limited, Ambit Private Limited, and Nuvama Wealth Management Limited are the book-running lead managers, and Link Intime India Private Limited is the registrar of the issue.